Skip to main content

Table 3 Rates of substrate (β-lactam) hydrolysis and inhibitor profiles of Acinetobacter spp. isolated from the ICU of Afzalipoor Hospital.

From: Antibiotic resistance patterns and extended-spectrum β-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran

Substrate

MIC (µg/mL)

β-lactamase

inhibitor

Substrate

hydrolysis (µmol)

CTX

>240

-

80± 0.04

CTX

>240

P-CMB (50mM)

80.2± 0.02

CTX

>240

NaCl (100mM)

2.1± 0.01

CTX

>240

Sulbactam (200µg/ml)

10.2± 0.03

CTX

>240

Clavulanic (200µg/ml)

7.5± 0.02

CAZ

>240

-

80± 0.04

CAZ

>240

P-CMB (50mM)

80.2± 0.02

CAZ

>240

NaCl (100mM)

2.1± 0.01

CAZ

>240

Sulbactam (200µg/ml)

30.2± 0.03

CAZ

>240

Clavulanic (200µg/ml)

7.5± 0.02

  1. β-lactamase inhibitors were added 15 min before addition of the substrate.
  2. P ≤ 0.05 was considered significant of association. The above results represent the mean of two independent experiments. Means and standard deviations (SD) were calculated as required for numerical variables.
  3. CTX = cefotaxime, CAZ = ceftazidime.